$120Million | No. of Holdings #77
Sectoral Asset Management Inc Performance
| Ticker | $ Bought |
|---|---|
| iqvia holdings inc | 1,416,680 |
| bristol myers squibb | 1,282,750 |
| medtronic plc | 961,815 |
| ardelyx inc | 781,060 |
| agomab therapeutics | 477,295 |
| abivax sa | 297,861 |
| medpace holdings | 228,090 |
| guardant health inc | 205,523 |
| Ticker | % Inc. |
|---|---|
| ars pharmaceuticals | 165 |
| insmed inc | 75.89 |
| gilead sciences inc | 53.7 |
| kura oncology inc | 32.1 |
| biontech se | 28.73 |
| boston scientific | 25.9 |
| cytokinetics inc | 23.88 |
| argenx se | 23.15 |
| Ticker | % Reduced |
|---|---|
| tectonic therapeutic | -54.9 |
| syndax pharmaceutics | -48.24 |
| structure therapeutics | -40.93 |
| rapport therapeutics | -34.69 |
| cogent biosciences | -32.26 |
| vera therapeutics | -30.62 |
| beone medicines ltd | -29.83 |
| omada health inc | -29.81 |
| Ticker | $ Sold |
|---|---|
| ventyx biosciences | -875,413 |
| carlsmed inc | -589,095 |
| amicus therapeutics | -616,592 |
| lenz therapeutics inc | -680,000 |
| astrazeneca | -1,400,280 |
| tempus ai inc | -265,725 |
| madrigal pharma | -204,984 |
SECTORAL ASSET MANAGEMENT INC has about 65% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 65 |
| Others | 34.5 |
SECTORAL ASSET MANAGEMENT INC has about 55% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 38.3 |
| UNALLOCATED | 34.5 |
| MEGA-CAP | 16.7 |
| MID-CAP | 5.6 |
| SMALL-CAP | 4.8 |
About 58.3% of the stocks held by SECTORAL ASSET MANAGEMENT INC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 45 |
| Others | 41.7 |
| RUSSELL 2000 | 13.3 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
SECTORAL ASSET MANAGEMENT INC has 77 stocks in it's portfolio. About 48.1% of the portfolio is in top 10 stocks. LLY proved to be the most loss making stock for the portfolio. was the most profitable stock for SECTORAL ASSET MANAGEMENT INC last quarter.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
Abbvie Inc Abbvie IncABBV Sectoral Asset Management Inc's holding in Abbvie Inc over time | 2.2% | 12,200 | $2.65M 2.2% | 27.38%decreased 27.38 percentreduced | |
Abbott Labs Abbott LabsABT Sectoral Asset Management Inc's holding in Abbott Labs over time | 2.17% | 25,578 | $2.63M 2.17% | 8.85%increased 8.85 percentadded | |
Alignment Health Alignment HealthALHC Sectoral Asset Management Inc's holding in Alignment Health over time | 0.39% | 26,911 | $474.2K 0.39% | 14.57%decreased 14.57 percentreduced | |
Alnylam Pharmacuetcl Sectoral Asset Management Inc's holding in Alnylam Pharmacuetcl over time | 0.72% | 2,310 | $864.2K 0.72% | 22.74%decreased 22.74 percentreduced | |
| 2.91% | 9,210 | $3.51M 2.91% | 29.53%decreased 29.53 percentreduced | ||
Ardelyx Inc Ardelyx IncARDX Sectoral Asset Management Inc's holding in Ardelyx Inc over time | 0.65% | 122,394 | $781.1K 0.65% | Newnew position | |
ARGX Argenx SeArgenx SeARGX | 2.27% | 3,564 | $2.74M 2.27% | 23.15%increased 23.15 percentadded | |
ASND Ascendis Pharma A SAscendis Pharma A SASND | 0.6% | 2,800 | $728.3K 0.6% | 13.95%decreased 13.95 percentreduced | |
Axsome Therapeutic Sectoral Asset Management Inc's holding in Axsome Therapeutic over time | 0.24% | 1,500 | $289.9K 0.24% | 13.79%decreased 13.79 percentreduced | |
AZN AstrazenecaAstrazenecaAZN | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Bridgebio Pharma Bridgebio PharmaBBIO Sectoral Asset Management Inc's holding in Bridgebio Pharma over time | 0.57% | 8,100 | $687.3K 0.57% | 27.48%decreased 27.48 percentreduced | |
Beone Medicines Ltd Sectoral Asset Management Inc's holding in Beone Medicines Ltd over time | 0.52% | 1,870 | $631.1K 0.52% | 29.83%decreased 29.83 percentreduced | |
Biogen Inc Biogen IncBIIB Sectoral Asset Management Inc's holding in Biogen Inc over time | 0.32% | 1,850 | $385.9K 0.32% | 14.15%decreased 14.15 percentreduced | |
Biomarin Pharmac Biomarin PharmacBMRN Sectoral Asset Management Inc's holding in Biomarin Pharmac over time | 0.5% | 9,450 | $607.3K 0.5% | 13.14%decreased 13.14 percentreduced | |
Bristol Myers Squibb Sectoral Asset Management Inc's holding in Bristol Myers Squibb over time | 1.06% | 21,150 | $1.28M 1.06% | Newnew position | |
BNTX Biontech SeBiontech SeBNTX | 1.69% | 22,164 | $2.05M 1.69% | 28.73%increased 28.73 percentadded | |
Boston Scientific Sectoral Asset Management Inc's holding in Boston Scientific over time | 1.81% | 34,780 | $2.18M 1.81% | 25.9%increased 25.9 percentadded | |
Cogent Biosciences Sectoral Asset Management Inc's holding in Cogent Biosciences over time | 0.75% | 22,140 | $902.4K 0.75% | 32.26%decreased 32.26 percentreduced | |
Cytokinetics Inc Cytokinetics IncCYTK Sectoral Asset Management Inc's holding in Cytokinetics Inc over time | 0.45% | 7,300 | $544.6K 0.45% | 23.88%increased 23.88 percentadded | |
Danaher Corp Danaher CorpDHR Sectoral Asset Management Inc's holding in Danaher Corp over time | 1.51% | 9,597 | $1.82M 1.51% | 9.25%decreased 9.25 percentreduced | |